Skip to content

CORMEDIX INC.: 10-Q filed 2011-08-09

What CORMEDIX INC. reported in its quarterly report filed 2011-08-09 (fiscal Q2 2011): 27 published measures, 85 facts as tagged in accession 0001144204-11-044696.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-09
Fiscal period
fiscal Q2 2011
Accession
0001144204-11-044696 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-304,949,452USD
At 2010-12-318,847,800USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-301,715,118USD
At 2010-12-311,592,402USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-303,234,334USD
At 2010-12-317,255,398USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-304,738,233USD
At 2010-12-318,283,684USD
At 2010-06-3010,585,717USD
At 2009-12-311,505,179USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-2,477,113USD91
2011-01-01 to 2011-06-30-4,452,151USD181
2006-07-28 to 2011-06-30-40,688,430USD1799
2010-04-01 to 2010-06-30-1,172,782USD91
2010-01-01 to 2010-06-30-7,640,369USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-3,543,826USD181
2006-07-28 to 2011-06-30-19,063,903USD1799
2010-01-01 to 2010-06-30-1,369,933USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,625USD181
2006-07-28 to 2011-06-3061,709USD1799
2010-01-01 to 2010-06-306,799USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2006-07-28 to 2011-06-3023,863,845USD1799
2010-01-01 to 2010-06-3010,457,270USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-1,625USD181
2006-07-28 to 2011-06-30-61,709USD1799
2010-01-01 to 2010-06-30-6,799USD181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-06-300USD181
2006-07-28 to 2011-06-30-280,920USD1799
2010-04-01 to 2010-06-300USD91
2010-01-01 to 2010-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-3017,770USD
At 2010-12-3122,310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-30431,087USD181
2006-07-28 to 2011-06-302,063,565USD1799
2010-01-01 to 2010-06-30466,399USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-2,480,372USD91
2011-01-01 to 2011-06-30-4,490,396USD181
2006-07-28 to 2011-06-30-30,318,039USD1799
2010-04-01 to 2010-06-30-1,178,465USD91
2010-01-01 to 2010-06-30-4,552,317USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-304,918,340USD
At 2010-12-318,812,148USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-06-300USD181
2006-07-28 to 2011-06-3011,193,028USD1799
2010-04-01 to 2010-06-300USD91
2010-01-01 to 2010-06-303,093,763USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-301,699,502USD
At 2010-12-311,575,643USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-06-301,436,817USD
At 2010-12-311,139,276USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-302,480,372USD91
2011-01-01 to 2011-06-304,490,396USD181
2006-07-28 to 2011-06-3030,318,039USD1799
2010-04-01 to 2010-06-301,178,465USD91
2010-01-01 to 2010-06-304,552,317USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,582,348USD91
2011-01-01 to 2011-06-302,757,890USD181
2006-07-28 to 2011-06-3020,815,339USD1799
2010-04-01 to 2010-06-30560,690USD91
2010-01-01 to 2010-06-303,287,699USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3011,408,274shares
At 2010-12-3111,408,274shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-06-30262,685USD
At 2010-12-31436,367USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-30149,932USD
At 2010-12-31323,060USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30898,024USD91
2011-01-01 to 2011-06-301,732,506USD181
2006-07-28 to 2011-06-309,502,700USD1799
2010-04-01 to 2010-06-30617,775USD91
2010-01-01 to 2010-06-301,264,618USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-306,165USD181
2006-07-28 to 2011-06-3043,939USD1799
2010-01-01 to 2010-06-305,727USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-01-01 to 2011-06-3029,819USD181
2006-07-28 to 2011-06-30420,987USD1799

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2006-07-28 to 2011-06-304,827USD1799
2010-01-01 to 2010-06-300USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30297,541USD181
2006-07-28 to 2011-06-301,436,817USD1799
2010-01-01 to 2010-06-30253,968USD181

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))